Lv5
950 积分 2023-03-21 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
Cytokine multimerization: when more is more and sometimes less
3个月前
已完结
Cell and gene therapy for kidney disease
3个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
4个月前
已完结
Target identification and assessment in the era of AI
4个月前
已完结
Anti-CD19 CAR T cells for refractory myasthenia gravis
4个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
4个月前
已完结
CD96 as a therapeutic target for CAR T cell therapy in acute myeloid leukemia
4个月前
已完结
CD3ɛ Nanobody‐Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE‐Secreting CAR‐Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity
4个月前
已完结
Optimizing translational efficiency in stem cell clinical research
5个月前
已完结
皖公网安备34019202002308
